[
  {
    "title": "多地血库“告急”！血制品概念股走高，卫光生物涨停",
    "href": "http://stock.jrj.com.cn/2022/12/29095837245324.shtml",
    "datetime": "2022-12-29 09:58:07",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：拟投资6500万元进行深圳湾实验室光明生物医药创新中心所需场地及相应基础配套建设",
    "href": "http://stock.jrj.com.cn/2022/12/16204137219464.shtml",
    "datetime": "2022-12-16 20:41:31",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：不超3434万股定增计划获批",
    "href": "http://stock.jrj.com.cn/2022/12/01180637182137.shtml",
    "datetime": "2022-12-01 18:06:04",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：定增申请获审核通过",
    "href": "http://stock.jrj.com.cn/2022/11/14192837137982.shtml",
    "datetime": "2022-11-14 19:28:47",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)第三季度净利润2588.33万元、同比下降61.77%",
    "href": "http://stock.jrj.com.cn/2022/10/30173337097465.shtml",
    "datetime": "2022-10-30 17:33:52",
    "code": "002880"
  },
  {
    "title": "卫光生物下调非公开发行股票方案募资总金额",
    "href": "http://stock.jrj.com.cn/2022/10/14151137055934.shtml",
    "datetime": "2022-10-14 15:11:11",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：定增申请获证监会受理",
    "href": "http://stock.jrj.com.cn/2022/09/05114136973179.shtml",
    "datetime": "2022-09-05 11:41:20",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)半年度净利润4688.67万元、同比下降32.98%",
    "href": "http://stock.jrj.com.cn/2022/08/30012236950028.shtml",
    "datetime": "2022-08-30 01:22:22",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：2021年年度权益分派10派2元 股权登记日7月7日",
    "href": "http://stock.jrj.com.cn/2022/07/01171436775673.shtml",
    "datetime": "2022-07-01 17:14:11",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：冻干人用狂犬病疫苗(鸡胚细胞)临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/05/20175636666432.shtml",
    "datetime": "2022-05-20 17:56:50",
    "code": "002880"
  },
  {
    "title": "卫光生物2022年第一季度净利2533.33万同比下滑6.13% 利息收入减少",
    "href": "http://stock.jrj.com.cn/2022/04/15113136342455.shtml",
    "datetime": "2022-04-15 11:31:49",
    "code": "002880"
  },
  {
    "title": "卫光生物2021年净利2.05亿同比增长7.9% 董事长张战薪酬107.71万",
    "href": "http://stock.jrj.com.cn/2022/04/15051036340216.shtml",
    "datetime": "2022-04-15 05:10:49",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)2021年度净利升7.90%至2.05亿元 拟10派2元",
    "href": "http://stock.jrj.com.cn/2022/04/14203436337621.shtml",
    "datetime": "2022-04-14 20:34:15",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)一季度净利润2533.33万元 同比下降6.13%",
    "href": "http://stock.jrj.com.cn/2022/04/14201836337239.shtml",
    "datetime": "2022-04-14 20:18:57",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：第二期员工持股计划已累计买入39.774万股",
    "href": "http://stock.jrj.com.cn/2022/03/14175734824800.shtml",
    "datetime": "2022-03-14 17:57:28",
    "code": "002880"
  },
  {
    "title": "投资者缘何用脚投票？卫光生物11.5亿元增发预案曝光股价直线下跌",
    "href": "http://stock.jrj.com.cn/2022/03/10082434807372.shtml",
    "datetime": "2022-03-10 08:24:00",
    "code": "002880"
  },
  {
    "title": "投资者缘何用脚投票？卫光生物11.5亿元增发预案曝光股价直线下跌",
    "href": "http://stock.jrj.com.cn/2022/03/10082434847143.shtml",
    "datetime": "2022-03-10 08:24:00",
    "code": "002880"
  },
  {
    "title": "投资者缘何用脚投票？卫光生物11.5亿元增发预案曝光股价直线下跌",
    "href": "http://stock.jrj.com.cn/2022/03/10082434849388.shtml",
    "datetime": "2022-03-10 08:24:00",
    "code": "002880"
  },
  {
    "title": "投资者缘何用脚投票？卫光生物11.5亿元增发预案曝光股价直线下跌",
    "href": "http://stock.jrj.com.cn/2022/03/10082434834223.shtml",
    "datetime": "2022-03-10 08:24:00",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：第二期员工持股计划尚未购买公司股票",
    "href": "http://stock.jrj.com.cn/2022/03/09213534627870.shtml",
    "datetime": "2022-03-09 21:35:27",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：2022年定增事项获得光明区国资局批复",
    "href": "http://stock.jrj.com.cn/2022/03/08221334542687.shtml",
    "datetime": "2022-03-08 22:13:44",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)拟定增募资不超11.5亿元 用于血液制品智能工厂建设项目等",
    "href": "http://stock.jrj.com.cn/2022/03/08221134542685.shtml",
    "datetime": "2022-03-08 22:11:43",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：第二期员工持股计划尚未购买公司股票",
    "href": "http://stock.jrj.com.cn/2022/02/08191634308575.shtml",
    "datetime": "2022-02-08 19:16:47",
    "code": "002880"
  },
  {
    "title": "卫光生物2021年预计净利1.9亿-2.28亿增长20% 销售毛利率提升",
    "href": "http://stock.jrj.com.cn/2022/01/27203134232013.shtml",
    "datetime": "2022-01-27 20:31:46",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)2021年度净利润预增0%-20%",
    "href": "http://stock.jrj.com.cn/2022/01/27173434231016.shtml",
    "datetime": "2022-01-27 17:34:56",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：第二期员工持股计划尚未购买公司股票",
    "href": "http://stock.jrj.com.cn/2022/01/07165434133912.shtml",
    "datetime": "2022-01-07 16:54:44",
    "code": "002880"
  },
  {
    "title": "卫光生物聘任岳章标为财务总监 第三季度公司净利6771.26万",
    "href": "http://stock.jrj.com.cn/2021/12/10051033992010.shtml",
    "datetime": "2021-12-10 05:10:57",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：聘任岳章标为财务总监",
    "href": "http://stock.jrj.com.cn/2021/12/09201233991307.shtml",
    "datetime": "2021-12-09 20:12:01",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)第三季度净利润6771.26万元 同比增长55.76%",
    "href": "http://stock.jrj.com.cn/2021/10/26194333756500.shtml",
    "datetime": "2021-10-26 19:43:09",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：第二期员工持股计划尚未购买公司股票",
    "href": "http://stock.jrj.com.cn/2021/10/14122133689890.shtml",
    "datetime": "2021-10-14 12:21:18",
    "code": "002880"
  },
  {
    "title": "卫光生物聘请郭采平担任总经理 上半年公司净利6996万",
    "href": "http://stock.jrj.com.cn/2021/09/29212633538490.shtml",
    "datetime": "2021-09-29 21:26:30",
    "code": "002880"
  },
  {
    "title": "卫光生物拟对外投资510万元设立控股子公司 持股51%",
    "href": "http://stock.jrj.com.cn/2021/09/23222533506939.shtml",
    "datetime": "2021-09-23 22:25:05",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：拟出资4000万元参与设立卫光鸿鹂投资基金",
    "href": "http://stock.jrj.com.cn/2021/09/23192933506125.shtml",
    "datetime": "2021-09-23 19:29:51",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：拟与卫光生命科技控股、深圳方略资本等等设卫光瑞康",
    "href": "http://stock.jrj.com.cn/2021/09/23191833506093.shtml",
    "datetime": "2021-09-23 19:18:21",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：拟向商业银行申请项目贷款不超6亿元",
    "href": "http://stock.jrj.com.cn/2021/09/23191533506057.shtml",
    "datetime": "2021-09-23 19:15:41",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：拟投资建设卫光生命科学园项目(二期)",
    "href": "http://stock.jrj.com.cn/2021/09/23191433506047.shtml",
    "datetime": "2021-09-23 19:14:25",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：第二期员工持股计划尚未购买公司股票",
    "href": "http://stock.jrj.com.cn/2021/09/10120033414216.shtml",
    "datetime": "2021-09-10 12:00:43",
    "code": "002880"
  },
  {
    "title": "卫光生物2021年半年度净利6996万元 同比净利减少9.73%",
    "href": "http://stock.jrj.com.cn/2021/08/20120033286139.shtml",
    "datetime": "2021-08-20 12:00:36",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：部分募投项目延期",
    "href": "http://stock.jrj.com.cn/2021/08/19213633282709.shtml",
    "datetime": "2021-08-19 21:36:25",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：上半年净利降9.73%至6996万元",
    "href": "http://stock.jrj.com.cn/2021/08/19195333282163.shtml",
    "datetime": "2021-08-19 19:53:21",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：第二期员工持股计划尚未购买公司股票",
    "href": "http://stock.jrj.com.cn/2021/08/11173533238152.shtml",
    "datetime": "2021-08-11 17:35:45",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：光明区国资局拟独立出资设深圳市卫光生命科技控股集团",
    "href": "http://stock.jrj.com.cn/2021/07/13165133089668.shtml",
    "datetime": "2021-07-13 16:51:19",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：第二期员工持股计划尚未购买公司股票",
    "href": "http://stock.jrj.com.cn/2021/07/08115933063416.shtml",
    "datetime": "2021-07-08 11:59:19",
    "code": "002880"
  },
  {
    "title": "卫光生物：卫光生命科学园坐落于光明科学城北部 相关工程正在紧锣密鼓的建设中",
    "href": "http://stock.jrj.com.cn/2021/06/21154632969563.shtml",
    "datetime": "2021-06-21 15:46:13",
    "code": "002880"
  },
  {
    "title": "卫光生物：公司在原料血浆开发、血液制品生产、新产品研发等方面都有着阶段性的进展",
    "href": "http://stock.jrj.com.cn/2021/06/21153632969467.shtml",
    "datetime": "2021-06-21 15:36:50",
    "code": "002880"
  },
  {
    "title": "卫光生物：公司目前已建立相关生产中试车间",
    "href": "http://stock.jrj.com.cn/2021/06/21153632969466.shtml",
    "datetime": "2021-06-21 15:36:41",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)2020年度权益分派10转4派2.5元 股权登记日为6月15日",
    "href": "http://stock.jrj.com.cn/2021/06/08204032895507.shtml",
    "datetime": "2021-06-08 20:40:24",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)拟推第二期员工持股计划 筹资上限为3000万元",
    "href": "http://stock.jrj.com.cn/2021/05/21191532794720.shtml",
    "datetime": "2021-05-21 19:15:04",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)拟推出第二期员工持股计划",
    "href": "http://stock.jrj.com.cn/2021/05/14114932754232.shtml",
    "datetime": "2021-05-14 11:49:25",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)一季度净利润降14.82%至2698.64万元",
    "href": "http://stock.jrj.com.cn/2021/04/28161232471893.shtml",
    "datetime": "2021-04-28 16:12:58",
    "code": "002880"
  },
  {
    "title": "卫光生物2020年净利增长11.12%优化营销模式 董事长张战薪酬104.04万",
    "href": "http://stock.jrj.com.cn/2021/04/23133832429608.shtml",
    "datetime": "2021-04-23 13:38:58",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)2020年净利升11.12%至1.90亿元 拟10转4派2.5元",
    "href": "http://stock.jrj.com.cn/2021/04/22233532426344.shtml",
    "datetime": "2021-04-22 23:35:56",
    "code": "002880"
  },
  {
    "title": "卫光生物：公司也在关注武汉禾元生物的植物源重组人血清白蛋白产品的进展",
    "href": "http://stock.jrj.com.cn/2021/04/15082232376791.shtml",
    "datetime": "2021-04-15 08:22:49",
    "code": "002880"
  },
  {
    "title": "卫光生物：3月16日是光大证券组织并主持的线上机构交流会",
    "href": "http://stock.jrj.com.cn/2021/04/15082232376789.shtml",
    "datetime": "2021-04-15 08:22:26",
    "code": "002880"
  },
  {
    "title": "卫光生物：公司的人凝血蛋白酶复合物目前仍在研发中",
    "href": "http://stock.jrj.com.cn/2021/04/15082232376788.shtml",
    "datetime": "2021-04-15 08:22:17",
    "code": "002880"
  },
  {
    "title": "卫光生物2021年第一季度预计净利2217.71万-3168.16万 较上年同期下滑0%-30%",
    "href": "http://stock.jrj.com.cn/2021/04/14144432371419.shtml",
    "datetime": "2021-04-14 14:44:44",
    "code": "002880"
  },
  {
    "title": "卫光生物2020年度净利增长11.12% 扩大销量",
    "href": "http://stock.jrj.com.cn/2021/04/14135332371109.shtml",
    "datetime": "2021-04-14 13:53:31",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)业绩快报：2020年度净利润升11.12%至1.90亿元",
    "href": "http://stock.jrj.com.cn/2021/04/13185932366416.shtml",
    "datetime": "2021-04-13 18:59:09",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)一季度净利润预降0%-30%",
    "href": "http://stock.jrj.com.cn/2021/04/13185632366410.shtml",
    "datetime": "2021-04-13 18:56:26",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：拟参与增资生物医药CDMO企业",
    "href": "http://stock.jrj.com.cn/2021/03/25193732217681.shtml",
    "datetime": "2021-03-25 19:37:30",
    "code": "002880"
  },
  {
    "title": "卫光生物：中国知名综合型生物医药企业 拟在楚雄州投建血液制品研发中心",
    "href": "http://stock.jrj.com.cn/2021/02/25210732027923.shtml",
    "datetime": "2021-02-25 21:07:38",
    "code": "002880"
  },
  {
    "title": "卫光生物2020年预计净利1.71亿-2.23亿增长0%-30% 血液制品销售收入增长",
    "href": "http://stock.jrj.com.cn/2021/01/31134431816489.shtml",
    "datetime": "2021-01-31 13:44:33",
    "code": "002880"
  },
  {
    "title": "卫光生物2020年预计净利1.71亿-2.23亿增长0%-30% 血液制品销售收入增长",
    "href": "http://stock.jrj.com.cn/2021/01/22200831747010.shtml",
    "datetime": "2021-01-22 20:08:43",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)2020年净利预增0%-30%",
    "href": "http://stock.jrj.com.cn/2021/01/22115431743734.shtml",
    "datetime": "2021-01-22 11:54:13",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：第一期员工持股计划股票锁定期1月16日届满",
    "href": "http://stock.jrj.com.cn/2021/01/15163631699047.shtml",
    "datetime": "2021-01-15 16:36:39",
    "code": "002880"
  },
  {
    "title": "卫光生物：目前公司新冠疫苗研发进度还处于临床前研究阶段",
    "href": "http://stock.jrj.com.cn/2021/01/08083031652481.shtml",
    "datetime": "2021-01-08 08:30:14",
    "code": "002880"
  },
  {
    "title": "卫光生物：卫光生命科学园未来将通过物业租金、投资收益、合作研发等多种形式创造收益",
    "href": "http://stock.jrj.com.cn/2021/01/08082931652479.shtml",
    "datetime": "2021-01-08 08:29:56",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)换发《药品生产许可证》",
    "href": "http://stock.jrj.com.cn/2020/12/23114731553084.shtml",
    "datetime": "2020-12-23 11:47:16",
    "code": "002880"
  },
  {
    "title": "卫光生物：与武汉禾元生物科技就重组生物制品领域建立战略合作关系",
    "href": "http://stock.jrj.com.cn/2020/12/21171331537396.shtml",
    "datetime": "2020-12-21 17:13:49",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：与成都海鹭生物签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2020/12/21160931536546.shtml",
    "datetime": "2020-12-21 16:09:47",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：与武汉禾元生物签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2020/12/21160831536535.shtml",
    "datetime": "2020-12-21 16:08:20",
    "code": "002880"
  },
  {
    "title": "A股异动 | 卫光生物(002880.SZ)涨超5% 与深圳先进技术研究院签订战略框架协议",
    "href": "http://stock.jrj.com.cn/2020/12/03143531399925.shtml",
    "datetime": "2020-12-03 14:35:37",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：与深圳先进技术研究院签订战略框架协议",
    "href": "http://stock.jrj.com.cn/2020/12/03115731398925.shtml",
    "datetime": "2020-12-03 11:57:23",
    "code": "002880"
  },
  {
    "title": "卫光生物：人凝血酶原复合物目前正在实施上市许可注册技术审评",
    "href": "http://stock.jrj.com.cn/2020/12/03105531398316.shtml",
    "datetime": "2020-12-03 10:55:24",
    "code": "002880"
  },
  {
    "title": "午间公告集锦：卫光生物签署三方合作协议推动CDMO平台落地",
    "href": "http://stock.jrj.com.cn/2020/11/13121531274600.shtml",
    "datetime": "2020-11-13 12:15:26",
    "code": "002880"
  },
  {
    "title": "卫光生物(002880.SZ)：与汉腾生物等签战略合作协议 推动大分子CDMO平台落地光明",
    "href": "http://stock.jrj.com.cn/2020/11/13115231274614.shtml",
    "datetime": "2020-11-13 11:52:03",
    "code": "002880"
  },
  {
    "title": "卫光生物2020年前三季度净利1.21亿增长10.57% 利息收入增加",
    "href": "http://stock.jrj.com.cn/2020/10/27211231144485.shtml",
    "datetime": "2020-10-27 21:12:11",
    "code": "002880"
  },
  {
    "title": "卫光生物：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/15081131057115.shtml",
    "datetime": "2020-10-15 08:11:40",
    "code": "002880"
  },
  {
    "title": "卫光生物2020年前三季度净利1.09亿-1.42亿 血液制品销售收入增长",
    "href": "http://stock.jrj.com.cn/2020/10/14213531054011.shtml",
    "datetime": "2020-10-14 21:35:28",
    "code": "002880"
  },
  {
    "title": "[互动]卫光生物：新冠单抗项目处临床前研究阶段",
    "href": "http://stock.jrj.com.cn/2020/09/04150530676635.shtml",
    "datetime": "2020-09-04 15:05:39",
    "code": "002880"
  },
  {
    "title": "卫光生物2020年上半年净利7750.04万增长9.88% 存款利息增加",
    "href": "http://stock.jrj.com.cn/2020/08/20225530552145.shtml",
    "datetime": "2020-08-20 22:55:10",
    "code": "002880"
  },
  {
    "title": "卫光生物投资设立全资子公司 投资金额1亿元",
    "href": "http://stock.jrj.com.cn/2020/07/30202830387153.shtml",
    "datetime": "2020-07-30 20:28:07",
    "code": "002880"
  },
  {
    "title": "卫光生物：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/10023030195827.shtml",
    "datetime": "2020-07-10 02:30:01",
    "code": "002880"
  },
  {
    "title": "卫光生物2020年上半年预计净利7053.31万元-9169.30万元 血液制品销售收入增长",
    "href": "http://stock.jrj.com.cn/2020/07/09195930194212.shtml",
    "datetime": "2020-07-09 19:59:51",
    "code": "002880"
  },
  {
    "title": "卫光生物：顺应粤港澳大湾区和深圳市生物医药产业政策趋势",
    "href": "http://stock.jrj.com.cn/2020/06/28190030071783.shtml",
    "datetime": "2020-06-28 19:00:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：控股子公司获得单采血浆许可证",
    "href": "http://stock.jrj.com.cn/2020/04/24200229369337.shtml",
    "datetime": "2020-04-24 20:02:38",
    "code": "002880"
  },
  {
    "title": "卫光生物2020年一季度预计净利2697.97万元-3507.36万元 同比增长0%-30%",
    "href": "http://stock.jrj.com.cn/2020/04/15114729294633.shtml",
    "datetime": "2020-04-15 11:47:34",
    "code": "002880"
  },
  {
    "title": "卫光生物：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15080029292251.shtml",
    "datetime": "2020-04-15 08:00:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：2019年净利润同比增长9.39% 拟10送5股派3.2元",
    "href": "http://stock.jrj.com.cn/2020/03/05221628961695.shtml",
    "datetime": "2020-03-05 22:16:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：2019年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2020/03/05221028961651.shtml",
    "datetime": "2020-03-05 22:10:00",
    "code": "002880"
  },
  {
    "title": "卫光生物2019年净利1.71亿元 加大营销力度",
    "href": "http://stock.jrj.com.cn/2020/03/05210228961345.shtml",
    "datetime": "2020-03-05 21:02:28",
    "code": "002880"
  },
  {
    "title": "卫光生物：2019年净利同比增长9.39% 拟10送5股派3.2元",
    "href": "http://stock.jrj.com.cn/2020/03/05201828961153.shtml",
    "datetime": "2020-03-05 20:18:25",
    "code": "002880"
  },
  {
    "title": "卫光生物：2019年净利同比增9.39% 拟10送5派3.2元",
    "href": "http://stock.jrj.com.cn/2020/03/05201828961157.shtml",
    "datetime": "2020-03-05 20:18:00",
    "code": "002880"
  },
  {
    "title": "卫光生物年报：2019年净利润1.71亿元 拟10送5股派3.2元",
    "href": "http://stock.jrj.com.cn/2020/03/05201428961130.shtml",
    "datetime": "2020-03-05 20:14:58",
    "code": "002880"
  },
  {
    "title": "卫光生物2019年净利1.72亿元 比上年同期增长10%",
    "href": "http://stock.jrj.com.cn/2020/02/27233228909513.shtml",
    "datetime": "2020-02-27 23:32:38",
    "code": "002880"
  },
  {
    "title": "卫光生物：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/30233028744013.shtml",
    "datetime": "2020-01-30 23:30:00",
    "code": "002880"
  },
  {
    "title": "卫光生物第三季度盈利1.73亿元 同比增长2%",
    "href": "http://stock.jrj.com.cn/2019/10/24105128292886.shtml",
    "datetime": "2019-10-24 10:51:30",
    "code": "002880"
  },
  {
    "title": "【卫光生物】大幅拉升3.43% 股价创近2个月新高",
    "href": "http://stock.jrj.com.cn/2019/09/11113128120511.shtml",
    "datetime": "2019-09-11 11:31:00",
    "code": "002880"
  },
  {
    "title": "卫光生物2019年上半年净利7053万 高原料血浆利用率",
    "href": "http://stock.jrj.com.cn/2019/08/29193128057328.shtml",
    "datetime": "2019-08-29 19:31:45",
    "code": "002880"
  },
  {
    "title": "[卫光生物]转载:光明区领导带队走访挂点服务企业 助生物医药行业发展",
    "href": "http://stock.jrj.com.cn/2019/08/16000028192960.shtml",
    "datetime": "2019-08-16 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]公司召开“不忘初心、牢记使命”主题教育退役军人座谈会",
    "href": "http://stock.jrj.com.cn/2019/08/06000028192961.shtml",
    "datetime": "2019-08-06 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]公司举办“防风险、除隐患、遏事故”主题活动",
    "href": "http://stock.jrj.com.cn/2019/08/06000028192962.shtml",
    "datetime": "2019-08-06 00:00:00",
    "code": "002880"
  },
  {
    "title": "卫光生物2019年上半年净利润7053万元 大力开拓新的销售区域",
    "href": "http://stock.jrj.com.cn/2019/07/24182427882770.shtml",
    "datetime": "2019-07-24 18:24:00",
    "code": "002880"
  },
  {
    "title": "卫光生物业绩快报：上半年净利润同比增长1.98%",
    "href": "http://stock.jrj.com.cn/2019/07/24173127882419.shtml",
    "datetime": "2019-07-24 17:31:07",
    "code": "002880"
  },
  {
    "title": "卫光生物：上半年净利7053万元 同比增1.98%",
    "href": "http://stock.jrj.com.cn/2019/07/24170327882156.shtml",
    "datetime": "2019-07-24 17:03:37",
    "code": "002880"
  },
  {
    "title": "卫光生物业绩快报：上半年净利同比增1.98%",
    "href": "http://stock.jrj.com.cn/2019/07/24164527882124.shtml",
    "datetime": "2019-07-24 16:45:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：已完成酒精储罐及回收塔消防安全隐患整治工程",
    "href": "http://stock.jrj.com.cn/2019/07/09160427816897.shtml",
    "datetime": "2019-07-09 16:04:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：关于限售股份解禁上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2019/07/03203027792764.shtml",
    "datetime": "2019-07-03 20:30:00",
    "code": "002880"
  },
  {
    "title": "卫光生物董事长王锦才辞职 2018年薪酬为90万元",
    "href": "http://stock.jrj.com.cn/2019/06/18081327718086.shtml",
    "datetime": "2019-06-18 08:13:50",
    "code": "002880"
  },
  {
    "title": "卫光生物获得人纤维蛋白原《药品 GMP 证书",
    "href": "http://stock.jrj.com.cn/2019/06/05115327666777.shtml",
    "datetime": "2019-06-05 11:53:08",
    "code": "002880"
  },
  {
    "title": "卫光生物：安全隐患整改方案已报送相关部门",
    "href": "http://stock.jrj.com.cn/2019/05/17184127587323.shtml",
    "datetime": "2019-05-17 18:41:00",
    "code": "002880"
  },
  {
    "title": "卫光生物一季度净利2698万同比增长9% 现金流量净额为-1551万元",
    "href": "http://stock.jrj.com.cn/2019/04/29075527504774.shtml",
    "datetime": "2019-04-29 07:55:42",
    "code": "002880"
  },
  {
    "title": "卫光生物去年净利1.57亿元 同比增长1% 董事长王锦才年薪90万元",
    "href": "http://stock.jrj.com.cn/2019/04/11230327369467.shtml",
    "datetime": "2019-04-11 23:03:46",
    "code": "002880"
  },
  {
    "title": "卫光生物：2018年净利同比增1.22% 拟10派3元",
    "href": "http://stock.jrj.com.cn/2019/04/11212427368939.shtml",
    "datetime": "2019-04-11 21:24:31",
    "code": "002880"
  },
  {
    "title": "卫光生物：2018年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2019/04/11211027368888.shtml",
    "datetime": "2019-04-11 21:10:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：获得人纤维蛋白原《药品补充生产批件》",
    "href": "http://stock.jrj.com.cn/2019/03/04174827115705.shtml",
    "datetime": "2019-03-04 17:48:57",
    "code": "002880"
  },
  {
    "title": "卫光生物2018年净利润1.57亿 国有股曾被划转给当地财政局",
    "href": "http://stock.jrj.com.cn/2019/02/25225527086160.shtml",
    "datetime": "2019-02-25 22:55:45",
    "code": "002880"
  },
  {
    "title": "卫光生物：获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/19080025370931.shtml",
    "datetime": "2018-11-19 08:00:01",
    "code": "002880"
  },
  {
    "title": "卫光生物：获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2018/11/16164525358558.shtml",
    "datetime": "2018-11-16 16:45:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/23203025247806.shtml",
    "datetime": "2018-10-23 20:30:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：获批设置万宁卫光单采血浆站",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/16075925208237.shtml",
    "datetime": "2018-10-16 07:59:58",
    "code": "002880"
  },
  {
    "title": "卫光生物：设置万宁卫光单采血浆站获批",
    "href": "http://stock.jrj.com.cn/2018/10/15175025205326.shtml",
    "datetime": "2018-10-15 17:50:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：拟投资1000万元设立全资子公司",
    "href": "http://stock.jrj.com.cn/hotstock/2018/09/11080025074294.shtml",
    "datetime": "2018-09-11 08:00:02",
    "code": "002880"
  },
  {
    "title": "卫光生物：拟投建血液制品研发与健康产业基地",
    "href": "http://stock.jrj.com.cn/hotstock/2018/09/11080025074291.shtml",
    "datetime": "2018-09-11 08:00:02",
    "code": "002880"
  },
  {
    "title": "卫光生物：拟在云南投建“血液制品研发与健康产业基地”",
    "href": "http://stock.jrj.com.cn/2018/09/10181525070910.shtml",
    "datetime": "2018-09-10 18:15:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/16221024963404.shtml",
    "datetime": "2018-08-16 22:10:00",
    "code": "002880"
  },
  {
    "title": "卫光生物：医药产业园项目资金来源于公司自有资金",
    "href": "http://stock.jrj.com.cn/2018/06/21104724709370.shtml",
    "datetime": "2018-06-21 10:47:43",
    "code": "002880"
  },
  {
    "title": "[卫光生物]卫光生物员工在光明集团2018年“五一”乒乓球比赛中勇获佳绩",
    "href": "http://stock.jrj.com.cn/2018/05/07000024879239.shtml",
    "datetime": "2018-05-07 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]公司荣获“深圳市五一劳动奖状”",
    "href": "http://stock.jrj.com.cn/2018/04/28000024879241.shtml",
    "datetime": "2018-04-28 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]欢欢喜喜闹元宵 齐心协力促发展",
    "href": "http://stock.jrj.com.cn/2018/03/02000024880373.shtml",
    "datetime": "2018-03-02 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]卫光生物开展“6S管理”活动",
    "href": "http://stock.jrj.com.cn/2018/02/13000024879236.shtml",
    "datetime": "2018-02-13 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]迎新春义写春联 送祝福翰墨飘香",
    "href": "http://stock.jrj.com.cn/2018/02/03000024879233.shtml",
    "datetime": "2018-02-03 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]卫光生物张战劳模创新工作室荣获“深圳市示范性劳模创新工作室”称号",
    "href": "http://stock.jrj.com.cn/2018/02/01000024879240.shtml",
    "datetime": "2018-02-01 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]坚持实干兴企,发扬工匠精神",
    "href": "http://stock.jrj.com.cn/2018/01/26000024880374.shtml",
    "datetime": "2018-01-26 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]第三次血液制品产业技术创新传略联盟大会在卫光生物顺利召开",
    "href": "http://stock.jrj.com.cn/2018/01/25000024879238.shtml",
    "datetime": "2018-01-25 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]关于 2017 年半年度募集资金存放与使用情况的专项报告",
    "href": "http://stock.jrj.com.cn/2017/08/31000023186970.shtml",
    "datetime": "2017-08-31 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]关于完成工商变更登记的公告",
    "href": "http://stock.jrj.com.cn/2017/08/25000023186972.shtml",
    "datetime": "2017-08-25 00:00:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]股票交易异常波动公告",
    "href": "http://stock.jrj.com.cn/2017/06/29000023181075.shtml",
    "datetime": "2017-06-29 00:00:00",
    "code": "002880"
  },
  {
    "title": "新股开板提示：卫光生物打开连续一字涨停板",
    "href": "http://stock.jrj.com.cn/2017/06/28095522665872.shtml",
    "datetime": "2017-06-28 09:55:00",
    "code": "002880"
  },
  {
    "title": "[卫光生物]上市首日风险提示公告",
    "href": "http://stock.jrj.com.cn/2017/06/16000023171861.shtml",
    "datetime": "2017-06-16 00:00:00",
    "code": "002880"
  },
  {
    "title": "永悦科技和卫光生物6月2日申购指南",
    "href": "http://stock.jrj.com.cn/ipo/2017/06/13065022601632.shtml",
    "datetime": "2017-06-13 06:50:08",
    "code": "002880"
  },
  {
    "title": "卫光生物网上发行中签率0.0251% 神器助力防弃购",
    "href": "http://stock.jrj.com.cn/ipo/2017/06/04171122570128.shtml",
    "datetime": "2017-06-04 17:11:33",
    "code": "002880"
  }
]